Oral Oncology
Volume 38, Issue 6 , Pages 521-526 , September 2002

Oral leukoplakia: a proposal for uniform reporting

  • I van der Waal

      Affiliations

    • Department of Oral & Maxillofacial Surgery/Pathology, Vrije Universiteit medical centre/ACTA, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31-20-444-4039; fax: +31-20-444-4046
  • ,
  • T Axéll

      Affiliations

    • Institute for Clinical Dentistry, University of Oslo, , PO Box 1109 Blindern, N-0317 Oslo, Norway

Received 11 November 2001 ,Accepted 21 November 2001.

References 

  1. Axéll T, Pindborg JJ, Smith CJ, Waal van der I  an International Collaborative Group on Oral White Lesions . Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18–21, 1994. J Oral Pathol Med. 1996;25:49–54
  2. Kramer IRH, Lucas RB, Pindborg JJ, Sobin LH  WHO Collaborating Centre for Oral Precancerous Lesions . Definition of leukopakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978;46:518–539
  3. Mehta FS, Hamner JE. Tobacco-related oral mucosal lesions and conditions in India. A guide for dental students, dentists, and physicians. Bombay: Basic Dental Research Unit, Tata Institute of Fundamental Research; 1993;
  4. In:  Sobin LH,  Wittekind Ch editor. UICC; TNM Classification of Malignant Tumours. 5th ed. International Union Against Cancer. New York-Toronto: John Wiley & Sons; 1997;
  5. Batsakis JG, Suarez P, El-Naggar AK. Proliferative verrucous leukoplakia and its related lesions. Oral Oncology. 1999;35:354–359
  6. Shiu MN, Chen TH, Chang SH, Hahn JL. Risk factors for leukoplakia and malignant transformation to oral carcinoma. Br J Cancer. 2000;82:1871–1874
  7. Gupta PC, Mehta FS, Daftary DK, Pindborg JJ, Bhonste RB, Jalnawalla PN, et al.  Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol. 1980;8:283–333
  8. Sudbø J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med. 2001;344:1270–1278
  9. Cruz IB, Snijders PJF, Meijer CJLM, Braakhuis BJ, Snow GB, Walboomers JM, et al.  p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol. 1998;184:360–368
  10. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, et al.  Predicting cancer development in oral leukoplakia: ten years of translation research. Clin Cancer Res. 2000;6:1702–1710
  11. Liu SC, Klein-Szanto AJP. Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncology. 2000;36:145–151
  12. Oliver RJ, MacDonald DG, Felix DH. Aspects of cell proliferation in oral dysplastic lesions. J Oral Pathol Med. 2000;29:49–55
  13. Karabalut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med. 1995;24:198–200
  14. Crissman JD, Gnepp DR, Goodman ML, Hellquist H, Johns ME. Preinvasive lesions of the upper aerodigestive tract: histologic definitions and clinical implications (a symposium). Pathology Annual. 1987;22:311–352
  15. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47:207–214
  16. Waal van der I, Schepman KP, Meij van der EH. A modified classification and staging system for oral leukoplakia. Oral Oncol. 2000;36:264–266
  17. Tradati N, Grigolat R, Calabrese L, Costa L, Giugliano G, Morelli F, et al.  Oral leukoplakias: to treat or not?. Oral Oncology. 1997;33:317–321
  18. Scully C. Oral precancer: preventive and medical approaches to management. Oral Oncol, Eur J Cancer. 1995;31B:16–26

PII: S1368-8375(01)00125-7

Oral Oncology
Volume 38, Issue 6 , Pages 521-526 , September 2002